Recent success of LNP safety has put the industry back in the spotlight. From personalized CRISPR treatments and Capstan’s phase I trial initiation for autoimmune diseases, to Verve’s recent clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback